跳至主要内容
临床试验/ISRCTN10736175
ISRCTN10736175进行中(未招募)1 期

Phase I trial: Quotient code QSC300553

Melinta Therapeutics (United States)0 个研究点目标入组 16 人开始时间: 2024年5月13日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

排除标准

  • The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

研究者

发起方
Melinta Therapeutics (United States)

相似试验